Literature DB >> 33514777

A risk progression breast epithelial 3D culture model reveals Cx43/hsa_circ_0077755/miR-182 as a biomarker axis for heightened risk of breast cancer initiation.

Nataly Naser Al Deen1, Nadia Atallah Lanman2,3, Shirisha Chittiboyina4, Sophie Lelièvre2,4, Rihab Nasr5, Farah Nassar6, Heinrich Zu Dohna1, Mounir AbouHaidar7, Rabih Talhouk8.   

Abstract

mRNA-circRNA-miRNAs axes have been characterized in breast cancer, but not as risk-assessment axes for tumor initiation in early-onset breast cancer that is increasing drastically worldwide. To address this gap, we performed circular RNA (circRNA) microarrays and microRNA (miRNA) sequencing on acini of HMT-3522 S1 (S1) breast epithelial risk-progression culture model in 3D and chose an early-stage population miRNome for a validation cohort. Nontumorigenic S1 cells form fully polarized epithelium while pretumorigenic counterparts silenced for gap junction Cx43 (Cx43-KO-S1) lose epithelial polarity, multilayer and mimic premalignant in vivo mammary epithelial morphology. Here, 121 circRNAs and 65 miRNAs were significantly dysregulated in response to Cx43 silencing in cultured epithelia and 15 miRNAs from the patient cohort were involved in epithelial polarity disruption. Focusing on the possible sponging activity of the validated circRNAs to their target miRNAs, we found all miRNAs to be highly enriched in cancer-related pathways and cross-compared their dysregulation to actual miRNA datasets from the cultured epithelia and the patient validation cohort. We present the involvement of gap junction in post-transcriptional axes and reveal Cx43/hsa_circ_0077755/miR-182 as a potential biomarker signature axis for heightened-risk of breast cancer initiation, and that its dysregulation patterns might predict prognosis along breast cancer initiation and progression.

Entities:  

Year:  2021        PMID: 33514777     DOI: 10.1038/s41598-021-82057-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  66 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Connexins: mechanisms regulating protein levels and intercellular communication.

Authors:  Vivian Su; Alan F Lau
Journal:  FEBS Lett       Date:  2014-01-20       Impact factor: 4.124

3.  Trends in stage at diagnosis for young breast cancer patients in the United States.

Authors:  Carol E DeSantis; Jiemin Ma; Ahmedin Jemal
Journal:  Breast Cancer Res Treat       Date:  2018-11-13       Impact factor: 4.872

Review 4.  The connexin 43 C-terminus: A tail of many tales.

Authors:  Edward Leithe; Marc Mesnil; Trond Aasen
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-05-16       Impact factor: 3.747

5.  BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.

Authors:  Nagi S El Saghir; Nathalie K Zgheib; Hussein A Assi; Katia E Khoury; Yannick Bidet; Sara M Jaber; Raghid N Charara; Rania A Farhat; Firas Y Kreidieh; Stephanie Decousus; Pierre Romero; Georges M Nemer; Ziad Salem; Ali Shamseddine; Arafat Tfayli; Jaber Abbas; Faek Jamali; Muhieddine Seoud; Deborah K Armstrong; Yves-Jean Bignon; Nancy Uhrhammer
Journal:  Oncologist       Date:  2015-03-16

6.  Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.

Authors:  Laura N Anderson; Michelle Cotterchio; Beatrice A Boucher; Nancy Kreiger
Journal:  Int J Cancer       Date:  2012-09-14       Impact factor: 7.396

Review 7.  Connexin 43, breast cancer tumor suppressor: Missed connections?

Authors:  Christina L Grek; J Matthew Rhett; Jaclynn S Bruce; Gautam S Ghatnekar; Elizabeth S Yeh
Journal:  Cancer Lett       Date:  2016-02-13       Impact factor: 8.679

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Effects of young age at presentation on survival in breast cancer.

Authors:  Nagi S El Saghir; Muhieddine Seoud; Mazen K Khalil; Maya Charafeddine; Ziad K Salem; Fady B Geara; Ali I Shamseddine
Journal:  BMC Cancer       Date:  2006-07-20       Impact factor: 4.430

10.  Connexins: a myriad of functions extending beyond assembly of gap junction channels.

Authors:  Hashem A Dbouk; Rana M Mroue; Marwan E El-Sabban; Rabih S Talhouk
Journal:  Cell Commun Signal       Date:  2009-03-12       Impact factor: 5.712

View more
  1 in total

1.  The BA-BCS 2021: An Initial "Trial" for Integrating Basic Science and Medical Progress on Breast Cancer in a Latin-American Country.

Authors:  Edith Kordon; Claudia Lanari; Pablo Mando; Virginia Novaro; Mario Rossi; Marina Simian
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-10-12       Impact factor: 2.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.